India's research and development sector funding for science, technology is stagnant: Quō vādis?
1US FDA grants emergency use authorisation to Regeneron antibody therapy given to Donald Trump
2WHO urges against remdesivir for COVID-19 as health experts clash on its effectiveness
3Oxford vaccine candidate found safe in elderly, offered immunity against SARS-CoV-2 in all age groups
4Biological E starts Phase I/II trial, Bharat Bio to begin Phase III trials for COVID-19 vaccine candidates
5Pandemics tied to fragmented forests, biodiversity loss? What science says, and India's response
6Volunteers needed for different kinds of COVID-19 vaccines, even for frontrunners in vaccine race
7Effective immunity to SARS-CoV-2 infection, once developed, could last years, new data hints
8Seven in ten younger COVID-19 patients show 'mild' organ damage months after infection
9CDC's new directive says that wearing a mask could keep you from catching the Coronavirus
10
